86 related articles for article (PubMed ID: 27477946)
1. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH).
Decamp M; Klein E; Godon C; Lestringant V; Roynard P; Theisen O; Jimenez-Pocquet M; Roche-Lestienne C; Bidet A; Veronese L
Curr Res Transl Med; 2023; 71(4):103424. PubMed ID: 38011761
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Tueur G; Quessada J; De Bie J; Cuccuini W; Toujani S; Lefebvre C; Luquet I; Michaux L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103434. PubMed ID: 38064905
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Bidet A; Quessada J; Cuccuini W; Decamp M; Lafage-Pochitaloff M; Luquet I; Lefebvre C; Tueur G;
Curr Res Transl Med; 2023; 71(4):103421. PubMed ID: 38016419
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
De Bie J; Quessada J; Tueur G; Lefebvre C; Luquet I; Toujani S; Cuccuini W; Lafage-Pochitaloff M; Michaux L
Curr Res Transl Med; 2023; 71(4):103431. PubMed ID: 38016418
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in the management of multiple Myeloma: The guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Daudignon A; Cuccuini W; Bracquemart C; Godon C; Quilichini B; Penther D
Curr Res Transl Med; 2023; 71(4):103427. PubMed ID: 38035476
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB; Chapiro E; Daudignon A; Nadal N; Penther D; Chauzeix J; Nguyen-Khac F; Veronese L; Lefebvre C
Curr Res Transl Med; 2023; 71(4):103428. PubMed ID: 38016421
[TBL] [Abstract][Full Text] [Related]
8. The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique.
Nguyen-Khac F; Muller M; Chapiro E; Abermil N; Collonge-Rame MA; Daudignon A; Gaillard B; Guzun D; Ittel A; Lefebvre C; Lesesve JF; Mozziconacci MJ; Penther D; Quessada J; Settegrana C; Smagghe L; Terre C; Veronese L; Hirsch P; Troadec MB
Am J Hematol; 2024 Jul; 99(7):1420-1422. PubMed ID: 38613825
[No Abstract] [Full Text] [Related]
9. Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.
Siebert R; Schuh A; Ott G; Cree IA; Du MQ; Ferry J; Hochhaus A; Naresh KN; Solary E; Khoury JD
Leukemia; 2023 May; 37(5):1170-1172. PubMed ID: 36973349
[No Abstract] [Full Text] [Related]
10. Cytogenetics in the management of hematological malignancies: Guidelines from the Groupe Francophone de Cytogénétique Hématologique.
Nguyen-Khac F; Bidet A; Chapiro E; Lefebvre C; Michaux L; Troadec MB
Curr Res Transl Med; 2023; 71(4):103411. PubMed ID: 37984195
[No Abstract] [Full Text] [Related]
11. Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nadal N; Auger N; Bidet A; Nguyen-Khac F
Curr Res Transl Med; 2023; 71(4):103426. PubMed ID: 38016423
[TBL] [Abstract][Full Text] [Related]
12. Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.
Véronèse L; Bensaber H; Dannus LT; Giannone G; Choiset C; Grimpret C; Abermil N; Balducci E; Bidet A; Chapiro E; Couronné L; Daudignon A; Douet-Gilbert N; Eclache V; Gaillard B; Gaillard JB; Hsoumi F; Lefebvre C; Nadal N; Mozziconacci MJ; Penther D; Ribourtout B; Richebourg S; Rigollet L; Terre C; Soler G; Tournilhac O; Guièze R; Nguyen-Khac F; Tchirkov A
Am J Hematol; 2024 May; ():. PubMed ID: 38817040
[No Abstract] [Full Text] [Related]
13. Summary and Review of the Abstracts on Philadelphia-Negative Myeloproliferative Neoplasms Presented at Haematocon 2017.
Chatterjee T; Ahuja A
Indian J Hematol Blood Transfus; 2018 Apr; 34(2):227-232. PubMed ID: 29622863
[TBL] [Abstract][Full Text] [Related]
14. Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
Combaluzier S; Quessada J; Abbou N; Arcani R; Tichadou A; Gabert J; Costello R; Loosveld M; Venton G; Berda-Haddad Y
Cells; 2023 Mar; 12(6):. PubMed ID: 36980287
[TBL] [Abstract][Full Text] [Related]
15. CT-derived relationship between low relative muscle mass and bone damage in patients with multiple myeloma undergoing stem cells transplantation.
Tagliafico AS; Rossi F; Bignotti B; Torri L; Bonsignore A; Belgioia L; Domineitto A
Br J Radiol; 2022 Apr; 95(1132):20210923. PubMed ID: 34918544
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetics in the management of Philadelphia-negative myeloproliferative neoplasms: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Bilhou-Nabéra C; Bidet A; Eclache V; Lippert E; Mozziconacci MJ
Ann Biol Clin (Paris); 2016 Oct; 74(5):517-523. PubMed ID: 27477946
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics in the management of "chronic myeloid leukemia": an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Roche-Lestienne C; Boudry-Labis E; Mozziconacci MJ
Ann Biol Clin (Paris); 2016 Oct; 74(5):511-515. PubMed ID: 27477825
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Nguyen-Khac F; Daudignon A; Eclache V; Lafage-Pochitaloff M; Lefebvre C; Luquet I; Penther D
Ann Biol Clin (Paris); 2016 Oct; 74(5):509-510. PubMed ID: 27465598
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Luquet I; Bidet A; Cuccuini W; Lafage-Pochitaloff M; Mozziconacci MJ; Terré C
Ann Biol Clin (Paris); 2016 Oct; 74(5):535-546. PubMed ID: 27545007
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
